ALEUP.PA stock at EURONEXT close €0.0384 26 Feb 2026: top loser outlook
The ALEUP.PA stock closed at €0.0384 on EURONEXT on 26 Feb 2026, positioning Europlasma among the session’s top losers as liquidity spiked. Trading volume reached 14,637,782 shares, about 5.68x the average, which underlined heavy selling pressure at the close of the market. Investors should note weak fundamentals — negative EPS and negative operating cash flow — alongside oversold technicals that could prompt short-term bounces or continued downside. This piece examines price action, drivers, the Meyka grade, technical targets and model forecasts to frame risk and opportunity for ALEUP.PA stock investors.
Price action and volume: ALEUP.PA stock at close
ALEUP.PA stock ended the EURONEXT session at €0.0384, unchanged from the previous close but down sharply from recent averages, with a day low €0.0340 and day high €0.0435. Volume was 14,637,782 vs average 1,227,855, producing a relative volume of 5.68, which signals unusually high trading interest and low liquidity. Market cap remains small at €90,758.00 and shares outstanding are 2,593,090, a structure that amplifies price moves on low absolute flows.
Drivers behind the drop: ALEUP.PA stock fundamentals and news
Weak reported fundamentals weigh on ALEUP.PA stock: EPS -88.61, negative margins and operating cash flow per share -0.0113 indicate ongoing losses and strained operations. Year-to-date performance shows a large decline and the year high sits at €81.75, illustrating historical illiquidity and corporate events that compressed the float. There is no consensus analyst price target and the next earnings date is listed as 29 Oct 2025, leaving little near-term guided catalyst. Recent market listings and quote pages flagged by media Investing.com compare and Cotation Europlasma underline thin coverage and retail-driven volatility.
Technical picture: ALEUP.PA stock shows oversold momentum
Technical indicators show ALEUP.PA stock is deeply oversold with RSI 13.28 and a strong directional trend signalled by ADX 70.58, meaning the downtrend carries force. Short-term resistance aligns with the Bollinger upper band at €0.07 and the 50-day average near €0.15, while the 200-day average sits at €5.92, reflecting a long-term collapse in price history. MACD histogram is slightly positive but limited; traders may watch a relief bounce toward €0.07–€0.15 on reduced selling, yet failure to hold €0.03 (year low €0.0296) would extend downside risk.
Meyka AI rates ALEUP.PA with a score out of 100: grade and valuation
Meyka AI rates ALEUP.PA with a score out of 100: 67.50 / Grade B — HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Key valuation and balance-sheet metrics: Price/Sales 0.00, EV €11,601,758.00, current ratio 0.77, debt-to-market-cap 146.05%, and negative free-cash-flow yield, which together explain the cautious HOLD suggestion. These grades are model outputs, not guarantees, and not financial advice.
Forecast and price targets: ALEUP.PA stock outlook
Meyka AI’s forecast model projects a monthly estimate of €0.11 and a quarterly projection of €0.99 for ALEUP.PA stock; these are model-based signals rather than guarantees. Compared with the current price €0.0384, the monthly projection implies an upside of +186.46%, while the quarterly projection implies +2,480.00%, illustrating model sensitivity to low base prices. A conservative technical target for risk-managed traders is €0.07 near-term and a cautious 12-month recovery target of €0.15; downside support remains near the year low €0.0296.
Risks and opportunities for ALEUP.PA stock investors
Primary risks: severe liquidity swings, continued negative EPS (-88.61), tight current ratio 0.77, and operational cash burn that could force dilution or restructuring. Opportunities: niche plasma torch technology, waste-to-energy exposure, asbestos treatment services and potential strategic transactions that could re-rate value. Given tiny market cap and outsized volume moves, we advise position sizing limits and non-directional hedges for traders considering ALEUP.PA stock exposure.
Final Thoughts
ALEUP.PA stock closed as one of the session’s top losers on EURONEXT at €0.0384 on 26 Feb 2026, driven by weak fundamentals, high relative volume (14,637,782, 5.68x avg) and persistent negative cash flow. Meyka AI assigns a 67.50 score (Grade B, HOLD) after weighing sector, growth and key metrics, which signals caution rather than an outright sell. Our model projects €0.11 monthly (implied +186.46%) and €0.99 quarterly (implied +2,480.00%); these figures are volatile given the low price base and should be treated as scenario outputs. Technicals show oversold conditions (RSI 13.28) that can produce short-lived bounces toward €0.07–€0.15, but failure to hold €0.03 risks further losses. Investors should expect high volatility, limited analyst coverage, and idiosyncratic corporate risk; use tight risk controls, limit exposure and monitor cash-flow or corporate-structure news. For more detail visit the Europlasma company page and quote sources; Meyka AI provides AI-powered market analysis and projections that complement traditional due diligence.
FAQs
Why did ALEUP.PA stock fall so sharply today?
ALEUP.PA stock fell as selling pressure spiked, driven by weak fundamentals (EPS -88.61), thin liquidity and heavy volume (14,637,782). Limited analyst coverage and no immediate positive catalysts increased downside sensitivity.
What are realistic near-term price targets for ALEUP.PA stock?
Near-term technical resistance sits at €0.07, with a cautious recovery target around €0.15 over 12 months; downside support is near the year low €0.0296. Targets reflect technicals and low liquidity.
How does Meyka AI grade affect the view on ALEUP.PA stock?
Meyka AI rates ALEUP.PA 67.50 (Grade B, HOLD) based on benchmarks, sector and financial metrics. The grade signals caution and reflects mixed fundamentals, not investment advice.
Are there catalysts that could change the ALEUP.PA stock outlook?
Potential catalysts include improved cash flow, strategic partnerships, asset sales or clearer guidance from management. Given thin coverage, any corporate update would likely create outsized moves in ALEUP.PA stock.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.